Wave Life Sciences (WVE) Non-Current Assets (2014 - 2026)

Wave Life Sciences (WVE) has 13 years of Non-Current Assets data on file, last reported at $50.8 million in Q2 2026.

• Quarterly Non-Current Assets rose 76.44% year-over-year to $50.8 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $50.8 million (up 76.44% YoY) and the FY2025 annual result came in at $23.7 million, down 25.55% from the prior year.
• Non-Current Assets grew to $50.8 million in Q2 2026, from $22.3 million in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $53.2 million in Q2 2022 to a low of $22.3 million in Q1 2026.
• A 5-year average of $38.4 million and a median of $39.0 million in 2023 frame the typical range for Non-Current Assets.
• The widest YoY moves for Non-Current Assets: up 76.44% in 2026, down 26.66% in 2026.
• Tracing WVE's Non-Current Assets over 5 years: stood at $47.8 million in 2022, then declined by 17.29% to $39.6 million in 2023, then dropped by 19.62% to $31.8 million in 2024, then fell by 25.55% to $23.7 million in 2025, then soared by 114.54% to $50.8 million in 2026.
• The last three Non-Current Assets figures came in at $50.8 million (Q2 2026), $22.3 million (Q1 2026), and $23.7 million (Q4 2025), per Business Quant data.